Research programme: small molecule isoxazoles - LoneStar Heart/University of Texas Southwestern Medical Center/University of Texas at San Antonio

Drug Profile

Research programme: small molecule isoxazoles - LoneStar Heart/University of Texas Southwestern Medical Center/University of Texas at San Antonio

Latest Information Update: 02 Aug 2016

Price : $50

At a glance

  • Originator LoneStar Heart; University of Texas Health Science Center at San Antonio; University of Texas Southwestern Medical Center
  • Class Isoxazoles; Small molecules
  • Mechanism of Action
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No
  • New Molecular Entity Yes

Highest Development Phases

  • Preclinical Diabetes mellitus; Heart failure

Most Recent Events

  • 02 Aug 2016 Preclinical trials in Heart failure in USA (unspecified route)
  • 02 Aug 2016 Preclinical trials in Diabetes mellitus in USA (unspecified route)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top